ALPMF Stock Price, Chart, Stats & News
Astellas Pharma Inc. (ALPMF) is a dividend-paying stock with a current dividend yield of 5.80% as of Aug 13, 2026. It pays $0.7801 per share over the trailing twelve months. Its dividend has grown at a 14.91% 5-year compound annual rate.
Dividend safety
Dividend coverage is moderate for ALPMF — it pays out about 60% of earnings.
ALPMF chart
About
Astellas Pharma Inc. operates as a global pharmaceutical enterprise, encompassing the development, manufacturing, distribution, and commercialization of medicinal products across international markets. Its diverse portfolio features prominent therapies such as XTANDI, an androgen receptor signaling inhibitor for prostate cancer, and XOSPATA, an FLT3 inhibitor targeting relapsed or refractory acute myeloid leukemia in adult patients with a specific FLT3 mutation. Other key offerings include PADCEV, designed for locally advanced or metastatic urothelial cancer, and the Betanis/Myrbetriq/BETMIGA family of beta-3 adrenergic receptor agonists used to alleviate symptoms of overactive bladder, including urgency, frequent urination, and urge incontinence.
Related lists
Similar securities
Based on sector and market capitalization
